Net profit of Gujarat Themis Biosyn declined 32.94% to Rs 12.54 crore in the quarter ended September 2023 as against Rs 18.70 crore during the previous quarter ended September 2022. Sales declined 16.86% to Rs 39.65 crore in the quarter ended September 2023 as against Rs 47.69 crore during the previous quarter ended September 2022.